Both in Pharmaceuticals
Arcturus Therapeutics Holdings vs Emergent Biosolutions
Over the past year ARCT returned +12.8% and EBS returned −27.6%; their daily moves had a correlation of 0.33.
ARCT +12.8% EBS −27.6%Growth of $1, one year, split-adjusted
| Metric | ARCT | EBS |
|---|---|---|
| Price | $10.65 | $6.81 |
| Market cap | $302.7M | $349.2M |
| Today | −12.35% | −5.68% |
| 1 month | −19.4% | +6.9% |
| 6 months | +23.4% | −19.6% |
| Year to date | +73.7% | −44.9% |
| 1 year | +12.8% | −27.6% |
| Revenue growth (YoY) | −89.5% | +66.3% |
| Gross margin | 100.0% | 58.6% |
| Net margin | −803.8% | −76.9% |
| P/E (TTM) | — | — |
| Price / sales | 10.3× | 0.5× |
| Net cash | $191.5M | -$442.1M |
| Dividend yield | — | — |
| Volatility (60d) | 116.5% | 67.4% |
| Short % of float | 19.2% | 19.3% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).